AEterna Laboratories Incorporated

Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal trials for the treatment of lung and kidney cancer, and multiple myeloma, a type of blood cancer.

Contact Details: 1405 Boul Parc-technologique Quebec Quebec G1P 4P5 Canada Tel: 418 652 8525 Fax: 418 652 0881 Email: WWW: www.aeterna.com/

Loading...

Recent Publications by AEterna Laboratories Incorporated:
Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agent. BACKGROUND: AE-941 (Neovastat) is an angiogenesis inhibitor noted to have...	1st July, 2005	AEterna Laboratories, Quebec, Quebec, Canada.	J Cutan Med Surg. 2003 May-Jun;7(3):208-16. DOI Direct Link

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 443 times since April 2007, the link to the organisation's website has been followed 105 times

Recent Search Terms used to find this page: Aeterna Laboratories | laboratori Aeterna neovastat | aeterna neovastat 2009 | .

Search for more companies in Quebec

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AEterna Laboratories Incorporated